头颈癌患者的决策冲突
这项前瞻性队列研究在三级癌症中心纳入2014年1月至2018年8月间接受根治性治疗的原发鳞状细胞癌患者,包括102例小喉鳞状细胞癌(SLSCC)患者和161例其他头颈鳞状细胞癌(HNSCC)患者,评估治疗决策咨询后2周内的决策冲突(DC)及其与生活质量和决策控制偏好的关联。结果显示,SLSCC组50例(50%)和其他HNSCC组74例(46%)存在临床显著DC(总分≥25),总队列中几乎一半患者(48%)存在临床显著DC,并识别出若干与DC相关的生活质量指标。
要点
- SLSCC组50%(51/102)和其他HNSCC组46%(74/161)存在临床显著决策冲突(DCS总分≥25)。
- SLSCC组中DCS总分≥25与<25的患者在EuroQol-5D、总体健康状况、HADS焦虑、HADS抑郁和VHI评分上差异较大,其他HNSCC组仅VHI有差异。
- 两组中控制偏好量表评分与决策冲突仅呈弱关联。
核心结论
- 这项队列研究发现几乎一半患者(48%)经历了临床显著的决策冲突,并识别出若干与临床显著决策冲突相关的生活质量指标;作者认为在减少决策延迟和决策相关痛苦方面仍有改进空间。
研究设计与样本
- 这项前瞻性队列研究包含2个独立队列,在三级癌症中心纳入2014年1月至2018年8月间符合原发鳞状细胞癌根治性治疗条件的患者。
- 2个队列共包括102例小喉鳞状细胞癌(SLSCC)患者和161例其他头颈鳞状细胞癌(HNSCC)患者。
主要发现
- 263例患者中50例(19%)为女性;SLSCC组平均(SD)年龄为66.1(11.4)岁,其他HNSCC组为64.9(9.8)岁。
- SLSCC组51例(50%)存在临床显著决策冲突(总分≥25),其他HNSCC组74例(46%)存在临床显著决策冲突。
- SLSCC组中DCS总分<25与≥25的患者在EuroQol-5D、总体健康状况、HADS焦虑、HADS抑郁和VHI评分上差异较大,其他HNSCC组仅VHI存在这种差异。
- SLSCC组44例(43.1%)认为治疗选择是共享决策,39例(38.2%)自行做出决策;其他HNSCC组62例(38.5%)认为由医生决策,56例(34.8%)认为是共享决策。
- 两组中控制偏好量表评分与决策冲突之间均呈弱关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Patients who experience less decisional conflict (DC) are more engaged in treatment and less prone to decisional regret, nervousness, and fretting. OBJECTIVES: To assess DC among patients with head and neck squamous cell carcinoma (HNSCC) after the treatment decision consultation and the association between DC and quality of life as well as the degree of control patients experience in the decision-making process using the control preference scale and the association with DC. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study with 2 separate cohorts was conducted at a tertiary cancer center and included patients who were eligible for curative treatment of a primary squamous cell carcinoma between January 2014 and August 2018. The 2 cohorts comprised 102 patients with small laryngeal squamous cell carcinoma (SLSCC) and 161 patients with other HNSCC. MAIN OUTCOMES AND MEASURES: Decisional Conflict Scale (DCS) score, which was scored within 2 weeks after the treatment decision consultation. Other measures included patient characteristics, tumor characteristics, and Control Preference Scale , EuroQol-5D, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30, Hospital Anxiety and Depression Scale (HADS), Eating Assessment Tool, and Voice Handicap Index (VHI) scores. RESULTS: Of 263 patients, 50 (19%) were women; the mean (SD) age was 66.1 (11.4) years in the SLSCC group and 64.9 (9.8) years in the other HNSCC group. In the SLSCC group, 51 patients (50%) experienced clinically significant DC (total score ≥25) compared with 74 patients (46%) in the other HNSCC group. In the SLSCC group, there was a large difference in the median EuroQol-5D, Global Health status, HADS anxiety, HADS depression, and VHI scores between the patients with a total DCS score of less than 25 and total DCS score of 25 or greater, whereas in the other HNSCC group, this only applied to the VHI. Forty-four patients (43.1%) in the SLSCC group felt their treatment choice was a shared decision, and 39 (38.2%) made the decision themselves. In the other HNSCC group, 62 (38.5%) felt that the physician decided, and 56 (34.8%) felt it was a shared decision. In both groups there was a weak association between control preference scale scores and DC. CONCLUSIONS AND RELEVANCE: The results of this cohort study found that almost half of patients (48%) experienced clinically significant DC. Several quality-of-life measures associated with clinically significant DC were identified. These results suggest that there is room for improvement in aiming to reduce decision delay and decision-related distress.
引用
- Hoesseini A, Dorr MC, Dronkers EAC, et al. Decisional Conflict in Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 36547952. doi:10.1001/jamaoto.2022.4269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。